BCAX: Notice of Proposed Sale of 2,963 Shares

BCAX issuer files a Form 144 proposing the sale of 2,963 common shares.

Accepted by SEC EDGAR 03/04/2026 - 04:32 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

BCAX issuer files a Form 144 proposing the sale of 2,963 common shares. The sale is listed as an exercise of stock options by the issuer for cash with an effective date of 03/04/2026.

The filing also lists past sales by Ivan Hyep: 9,200 shares on 12/22/2025, 1,882 shares on 01/22/2026, and 13,555 shares on 03/03/2026, with the dollar proceeds shown for each sale.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does BCAX's Form 144 disclose about the proposed sale?

The Form 144 discloses an issuer sale of 2,963 common shares tied to an exercise of stock options and listed as a cash transaction on 03/04/2026. It is recorded on NASDAQ.

Who reported recent open‑market sales in the filing for BCAX?

The filing lists multiple prior sales attributed to Ivan Hyep: 9,200 shares on 12/22/2025, 1,882 shares on 01/22/2026, and 13,555 shares on 03/03/2026, with proceeds shown per sale.

What transaction type is noted for the 2,963 BCAX shares?

The 2,963 shares are reported as resulting from an exercise of stock options and the method of sale is indicated as cash, with the sale date of 03/04/2026.

Are dollar proceeds shown in the BCAX Form 144 entries?

Yes. The prior sales by Ivan Hyep include proceeds: $168,491.56 for 9,200 shares, $34,162.44 for 1,882 shares, and $246,909.75 for 13,555 shares, as listed in the filing.

Which marketplace is identified for the securities in the BCAX filing?

The filing lists the market as NASDAQ for the common shares associated with the reported transactions and the proposed sale on 03/04/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002034668
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Bicara Therapeutics Inc.
SEC File Number	001-42271
Address of Issuer	116 HUNTINGTON AVENUE SUITE 703 BOSTON MASSACHUSETTS 02116
Phone	617-468-4219
Name of Person for Whose Account the Securities are To Be Sold	Hyep Ivan
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	2963	54061.71	54781950	03/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/04/2026	Exercise of stock options	Issuer			2963	03/04/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Ivan Hyep 116 HUNTINGTON AVENUE SUITE 703 Boston MA 02116	Common	12/22/2025	9200	168491.56
Ivan Hyep 116 HUNTINGTON AVENUE SUITE 703 Boston MA 02116	Common	01/22/2026	1882	34162.44
Ivan Hyep 116 HUNTINGTON AVENUE Suite 703 Boston MA 02116	Common	03/03/2026	13555	246909.75

144: Remarks and Signature

Remarks
Date of Notice	03/04/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/13/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc., as attorney-in-fact for Ivan Hyep
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)